Maternal and paternal exposure to antiepileptics and risk of adverse pregnancy, neonatal and child outcomes (ADEPT)

Project information

• EU PE&PV research network
• EUPAS1000000212
• EUPAS1000000246
• Specific Contract 03 implementing Framework service contract EMA/2020/46/TDA/L5.06 

Full title

Use of antiepileptics, and feasibility of studies on the association between maternal and paternal exposure to antiepileptics and risk of adverse pregnancy, neonatal and child outcomes

Principal investigator

Prof. Dr. Miriam Sturkenboom, UMC Utrecht

Participating organisations

• Utrecht University, The Netherlands (consortium lead, project co-lead)
• University Medical Center Utrecht (UMCU), The Netherlands (project co-lead)
• Fundación FISABIO, Spain (project co-lead)
• Finnish Institute for Health and Welfare (THL), Finland
• University of Toulouse, France
• Agenzia Regionale di Sanità (ARS Toscana), Italy
• INSPIRE, Italy
• University of Oslo, Norway
• Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), Spain
• FISABIO, Spain
• Fundacio Hospital Universitari Vall d’Hebron Institut de Recerca (VHIR), Spain
• Institut Universitari d’Investigació en Atenció Primària (IDIAPJGol), Spain
• PHARMO Institute, The Netherlands
• University of Manchester, UK

Status

Started in April 2024, ongoing

Deliverables

Study protocol